Drive efficiencies during development and production
- Freedom to choose - any media, vector or CRO/CMO
- Freedom to operate – no patent or IP risks
- Maintain profitability throughout product life cycle - royalty-free licensing
Gene editing CHO cell services
- Improve your CHO cell performance
- Meet demands for cost-effective biomanufacturing
- Ensure a clear IP position with freedom to operate
News highlights
- CHOSOURCE™ platform supports development of immunotherapy for autoimmune diseases
- CHOSOURCE™ platform offered for COVID-19-related therapeutics and diagnostics
- Multi-product use license of GS knockout CHO K1 cell line granted to NGM Bio
- Glenmark adopts CHO cell line into biomanufacturing process
Regulatory Compliant – no royalty fees
Innovative and flexible approach to licensing
CHO Functional Genomic Screening
Use CRISPR screening to optimize your CHO cell line
